Skip to main content

Halobetasol News

FDA Approves Duobrii (halobetasol propionate and tazarotene) Lotion 0.01%/0.045% for Plaque Psoriasis In Adults

LAVAL, Quebec, April 25, 2019 /PRNewswire/ – Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care...

Bausch Health Announces U.S. Launch of Bryhali (halobetasol propionate) Lotion, 0.01%, for Plaque Psoriasis In Adults

LAVAL, Quebec, Nov. 7, 2018 /PRNewswire/ – Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Plaque Psoriasis, Eczema, Psoriasis, Contact Dermatitis, Atopic Dermatitis, Dermatitis

Halobetasol patient information at Drugs.com